T he probability that Medicare reform legislation will pass in 2003 seems as volatile as the stock market. After rapid passage of bills in the Senate and House in June, hopes that differences would be quickly reconciled have given way to concerns about the tough issues that still need to be resolved. Clearly, the commitment of $400 billion for prescription drug coverage would be a major step fo...